Get started

Buyopportunity

Opportunity to buy into WMTThis is a personal publication that I am posting public for those who are following me and watching my account grow. There are a lot of indicators that are showing a near term drop for Walmart, this would create a good buy in point. Since we are in a bull market, we should expect Walmart to rise the remainder of the year. Why do I think there will be a small drop in the short term? High RSI: 65 Bollinger bands about to cross at a high point indicating a sell signal. Growing bearish strength on the divergence indicator. MACD: Showing weakening bullish divergence Candles are also moving down closer to the Moving Average As an options trader a small dip could lower options cost for an opportunity to buy more contracts and make more money. Stay Tuned for updates!
NYSE:WMTLong
by Myantman101
ACHV Achieve Life Sciences 10X potential! Highest undervalued!On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is how much upside potential does it have. On July 31 ACHIEVE ANNOUNCES PATENT GRANTED IN THE U.S. FOR NOVEL ANALOGS OF CYTISINICLINE FOR USE IN CNS AND ADDICTION INDICATIONS. Also Short Interest in Achieve Life Sciences Inc Drops By 81.1%. Achieve Life Sciences issued its quarterly earnings results on Aug 4th. The biopharmaceutical company reported ($1.68) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.80) by $2.12, Fidelity Earnings reports. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:ACHVLong
by TopgOptions
2
RMED RA Medical Systems Inc upside potentialRa Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. They have a debt of 56.957M, but also a small market cap of 11.314M. 6/12/2020 Richard Mejia Jr Director Buys 50,000 shares 5/29/2020 William R Enquist Director Buys 50,000 shares You can double your money quite fast. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
RLong
by TopgOptions
JAGX Would you buy something that was 10000x more expensive? Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required technical section to support approval of Jaguar's oral plant-based drug candidate Canalevia™ (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea in dogs, although this filing was originally scheduled for submission by the end of August 2020. More than 230,000 dogs in the U.S. receive chemotherapy treatment for various cancers each year, and roughly one in four (more than 50,000 dogs) will experience diarrhea as a side effect of treatment. OASIS CAPITAL LLC REPORTS 9.99% PASSIVE STAKE IN JAGUAR HEALTH AS OF JULY 7- SEC FILING Net Income $-38,540,000 Market Cap $42.15 million Annual Sales $5.78 million Debt-to-Equity Ratio 0.08 JAGX is a risky bet that can double your money in seconds. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:JAGXLong
by TopgOptions
5